Patents by Inventor Matthew D. Hall

Matthew D. Hall has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100316655
    Abstract: Disclosed herein are drug compounds that have MDR-inverse activity and thus are effective against multidrug-resistant cells. Exemplary compounds disclosed herein have the structure: Examples of the disclosed compounds have been found to have, inter alia, efficacy in directly treating multidrug resistant cells, rendering multidrug resistant cells susceptible to other chemotherapeutics and in some instances reversing multidrug resistance.
    Type: Application
    Filed: February 10, 2009
    Publication date: December 16, 2010
    Inventors: Matthew D. Hall, Michael M. Gottesman, Jennifer L. Hellawell, Joseph A. Ludwig, Henry M. Fales, Noeris K. Salam, Gergely Szakács
  • Patent number: D1015976
    Type: Grant
    Filed: May 27, 2022
    Date of Patent: February 27, 2024
    Assignee: FCA US LLC
    Inventors: Nicholas A. Malachowski, Eugenio Sellaro-Neto, Matthew W. Dunford, Alexander Tannen, Chris Piscitelli, Jeffrey C. Gale, Mark D. Hall, Mark T. Allen
  • Patent number: D1015977
    Type: Grant
    Filed: May 27, 2022
    Date of Patent: February 27, 2024
    Assignee: FCA US LLC
    Inventors: Nicholas A. Malachowski, Eugenio Sellaro-Neto, Matthew W. Dunford, Alexander Tannen, Chris Piscitelli, Jeffrey C. Gale, Mark D. Hall, Mark T. Allen
  • Patent number: D1017483
    Type: Grant
    Filed: May 27, 2022
    Date of Patent: March 12, 2024
    Assignee: FCA US LLC
    Inventors: Nicholas A. Malachowski, Eugenio Sellaro-Neto, Matthew W. Dunford, Alexander Tannen, Chris Piscitelli, Jeffrey C. Gale, Mark D. Hall, Mark T. Allen